ketamine has been researched along with Cirrhosis in 10 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketamine-induced cystitis (KIC) is a disease caused by ketamine that can cause lower urinary tract symptoms (LUTS)." | 8.12 | Transcriptomic analysis of bladder tissue in a rat model of ketamine-induced bladder fibrosis. ( Li, H; Li, K; Tang, Z; Wang, Z; Zhu, Q, 2022) |
| "To investigate the mechanism of bladder nerve hyperplasia and fibrosis in the patients with ketamine-associated cystitis (KC)." | 7.91 | Upregulation of neurotrophins and transforming growth factor-β expression in the bladder may lead to nerve hyperplasia and fibrosis in patients with severe ketamine-associated cystitis. ( Birder, LA; Hsu, YH; Jhang, JF; Kuo, HC; Wang, HJ, 2019) |
| "Bladder wall fibrosis is a major complication of ketamine-induced cystitis (KC), but the underlying pathogenesis is poorly understood." | 7.85 | Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1. ( Chen, J; Chen, Y; Gu, D; Wang, J; Wu, P; Zhang, G; Zhao, J, 2017) |
| "Abuse of the hallucinogenic drug ketamine promotes the development of lower urinary tract symptoms that resemble interstitial cystitis." | 7.83 | Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder. ( Choi, SJ; Choo, MS; Heo, J; Kim, A; Kim, SW; Kim, Y; Lee, S; Lim, J; Oh, W; Shin, DM; Shin, JH; Song, M; Yoon, SJ; Yu, HY, 2016) |
| "Anesthesia was induced by intramuscular administration of ketamine and xylazine followed by infusion of lactated Ringer's solution also containing ketamine and xylazine." | 7.70 | Cardiovascular pathology possibly associated with ketamine/xylazine anesthesia in Dutch belted rabbits. ( Dangler, C; Harpster, NK; Li, X; Marini, RP, 1999) |
| "Ketamine-treated rats were found to display bladder hyperactivity." | 5.42 | Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum. ( Chuang, SM; Ho, WT; Jang, MY; Juan, YS; Lee, YL; Lin, RJ; Liu, KM; Long, CY; Lu, JH; Lu, MC; Wang, CC; Wu, WJ, 2015) |
| "Ketamine-induced cystitis (KIC) is a disease caused by ketamine that can cause lower urinary tract symptoms (LUTS)." | 4.12 | Transcriptomic analysis of bladder tissue in a rat model of ketamine-induced bladder fibrosis. ( Li, H; Li, K; Tang, Z; Wang, Z; Zhu, Q, 2022) |
| "To investigate the mechanism of bladder nerve hyperplasia and fibrosis in the patients with ketamine-associated cystitis (KC)." | 3.91 | Upregulation of neurotrophins and transforming growth factor-β expression in the bladder may lead to nerve hyperplasia and fibrosis in patients with severe ketamine-associated cystitis. ( Birder, LA; Hsu, YH; Jhang, JF; Kuo, HC; Wang, HJ, 2019) |
| "Bladder wall fibrosis is a major complication of ketamine-induced cystitis (KC), but the underlying pathogenesis is poorly understood." | 3.85 | Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1. ( Chen, J; Chen, Y; Gu, D; Wang, J; Wu, P; Zhang, G; Zhao, J, 2017) |
| "Abuse of the hallucinogenic drug ketamine promotes the development of lower urinary tract symptoms that resemble interstitial cystitis." | 3.83 | Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder. ( Choi, SJ; Choo, MS; Heo, J; Kim, A; Kim, SW; Kim, Y; Lee, S; Lim, J; Oh, W; Shin, DM; Shin, JH; Song, M; Yoon, SJ; Yu, HY, 2016) |
| "Chronic treatment with ketamine caused significant ventricular myocardial apoptosis, fibrosis and sympathetic sprouting, which altered the electrophysiological properties of the heart and increased its susceptibility to malignant arrhythmia that may lead to sudden cardiac death." | 3.78 | Ketamine-induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol. ( Dong, DL; Geng, JQ; Gong, YT; Gong, ZH; Han, CL; Li, WM; Li, Y; Liu, GZ; Liu, L; Pan, ZW; Sheng, L; Shi, J; Sun, DH; Tan, XY; Yang, BF, 2012) |
| "Anesthesia was induced by intramuscular administration of ketamine and xylazine followed by infusion of lactated Ringer's solution also containing ketamine and xylazine." | 3.70 | Cardiovascular pathology possibly associated with ketamine/xylazine anesthesia in Dutch belted rabbits. ( Dangler, C; Harpster, NK; Li, X; Marini, RP, 1999) |
| "Ketamine-treated rats were found to display bladder hyperactivity." | 1.42 | Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum. ( Chuang, SM; Ho, WT; Jang, MY; Juan, YS; Lee, YL; Lin, RJ; Liu, KM; Long, CY; Lu, JH; Lu, MC; Wang, CC; Wu, WJ, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H | 1 |
| Li, K | 1 |
| Zhu, Q | 1 |
| Tang, Z | 1 |
| Wang, Z | 1 |
| Jhang, JF | 1 |
| Wang, HJ | 1 |
| Hsu, YH | 1 |
| Birder, LA | 1 |
| Kuo, HC | 1 |
| Wang, J | 1 |
| Chen, Y | 1 |
| Gu, D | 1 |
| Zhang, G | 1 |
| Chen, J | 1 |
| Zhao, J | 1 |
| Wu, P | 1 |
| Liu, KM | 1 |
| Chuang, SM | 1 |
| Long, CY | 1 |
| Lee, YL | 1 |
| Wang, CC | 1 |
| Lu, MC | 1 |
| Lin, RJ | 1 |
| Lu, JH | 1 |
| Jang, MY | 1 |
| Wu, WJ | 1 |
| Ho, WT | 1 |
| Juan, YS | 1 |
| Song, M | 2 |
| Yu, HY | 2 |
| Chun, JY | 1 |
| Shin, DM | 2 |
| Song, SH | 1 |
| Choo, MS | 2 |
| Song, YS | 1 |
| Shen, CH | 1 |
| Wang, SC | 1 |
| Wang, ST | 1 |
| Lin, SM | 1 |
| Wu, JD | 1 |
| Lin, CT | 1 |
| Liu, YW | 1 |
| Kim, A | 1 |
| Heo, J | 1 |
| Shin, JH | 1 |
| Lim, J | 1 |
| Yoon, SJ | 1 |
| Kim, Y | 1 |
| Lee, S | 1 |
| Kim, SW | 1 |
| Oh, W | 1 |
| Choi, SJ | 1 |
| Li, Y | 1 |
| Shi, J | 1 |
| Yang, BF | 1 |
| Liu, L | 1 |
| Han, CL | 1 |
| Li, WM | 1 |
| Dong, DL | 1 |
| Pan, ZW | 1 |
| Liu, GZ | 1 |
| Geng, JQ | 1 |
| Sheng, L | 1 |
| Tan, XY | 1 |
| Sun, DH | 1 |
| Gong, ZH | 1 |
| Gong, YT | 1 |
| Tao, Y | 1 |
| Chen, XP | 1 |
| Qin, ZH | 1 |
| Marini, RP | 1 |
| Li, X | 1 |
| Harpster, NK | 1 |
| Dangler, C | 1 |
10 other studies available for ketamine and Cirrhosis
| Article | Year |
|---|---|
Transcriptomic analysis of bladder tissue in a rat model of ketamine-induced bladder fibrosis.
Topics: Animals; Cystitis; Female; Fibrosis; Gene Expression Profiling; Humans; Ketamine; Male; Rats; Rats, | 2022 |
Upregulation of neurotrophins and transforming growth factor-β expression in the bladder may lead to nerve hyperplasia and fibrosis in patients with severe ketamine-associated cystitis.
Topics: Adult; Aged; Brain-Derived Neurotrophic Factor; Cystitis; Excitatory Amino Acid Antagonists; Female; | 2019 |
Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1.
Topics: Analgesics; Animals; Cell Line; Cystitis; Epithelial-Mesenchymal Transition; Female; Fibroblasts; Fi | 2017 |
Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum.
Topics: Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Cystitis; Disease Model | 2015 |
The fibrosis of ketamine, a noncompetitive N-methyl-d-aspartic acid receptor antagonist dose-dependent change in a ketamine-induced cystitis rat model.
Topics: Animals; Cystitis; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid A | 2016 |
Evaluation of urinary bladder fibrogenesis in a mouse model of long-term ketamine injection.
Topics: Animals; Disease Models, Animal; Female; Fibrosis; Injections, Intraperitoneal; Ketamine; Male; Mice | 2016 |
Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder.
Topics: Analgesics; Animals; Cells, Cultured; Cystitis; Disease Models, Animal; Fibrosis; Humans; Infant, Ne | 2016 |
Ketamine-induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol.
Topics: Analgesics; Animals; Apoptosis; Apoptosis Inducing Factor; Fibrosis; Heart Ventricles; Illicit Drugs | 2012 |
A fatal chronic ketamine poisoning.
Topics: Adult; Anesthetics, Dissociative; Autopsy; Chronic Disease; Female; Fibrosis; Homicide; Humans; Keta | 2005 |
Cardiovascular pathology possibly associated with ketamine/xylazine anesthesia in Dutch belted rabbits.
Topics: Anesthesia; Anesthetics; Animals; Antibodies, Viral; Cardiovascular Diseases; Coronavirus; Echocardi | 1999 |